Condition
Metastatic Soft Tissue Sarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Metastatic Soft Tissue Sarcoma clinical trials that are recruiting, at sites in 5 countries (most in United States (5), Belgium (1), France (1)). By phase: Phase 1/2 (4), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Metastatic Soft Tissue Sarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing a new treatment for soft tissue sarcoma | Phase 1/2 | Aurora, Colorado and 8 other locations | Recruiting | Jan 29, 2025 |
| Adding abemaciclib to gemcitabine chemotherapy for advanced soft tissue sarcoma | Phase 1/2 | Houston, Texas | Recruiting | Jul 12, 2024 |
| Membrane-anchored IL-12–modified TIL (attIL12-TIL) therapy for advanced soft tissue and bone sarcoma | Phase 1 | Houston, Texas | Recruiting | Jun 26, 2024 |
| Using pulmonary suffusion to control minimal residual disease in sarcoma and colorectal cancer patients | Phase 1/2 | Buffalo, New York | Recruiting | May 28, 2019 |
| Combination treatment for advanced soft tissue sarcoma | Phase 1/2 | Santa Monica, California | Recruiting | May 3, 2017 |
All recruiting trials (5)
-
Testing a new treatment for soft tissue sarcoma
This study is testing a new treatment called ADCE-D01 to see if it can help people with advanced soft tissue sarcoma feel better and live longer.
-
Adding abemaciclib to gemcitabine chemotherapy for advanced soft tissue sarcoma
This phase 1/2 trial tests whether adding the targeted drug abemaciclib to gemcitabine is safe and works better than gemcitabine plus docetaxel for adults with advanced or metastatic leiomyosarcoma or dedifferentiated liposarcoma whose tumors are Rb-positive.
-
Membrane-anchored IL-12–modified TIL (attIL12-TIL) therapy for advanced soft tissue and bone sarcoma
This trial tries T cells engineered to carry membrane-anchored IL-12 (attIL12-TIL), given with cyclophosphamide, for people with relapsed or metastatic soft tissue or bone sarcomas, with a liposarcoma expansion group.
-
Using pulmonary suffusion to control minimal residual disease in sarcoma and colorectal cancer patients
This study is testing a new way to deliver chemotherapy directly to the lungs in patients with sarcoma or colorectal cancer that has spread there, to see if it helps control the disease better and is safe to use.
-
Combination treatment for advanced soft tissue sarcoma
This study is testing a new combination of treatments using Trabectedin, Ipilimumab, and Nivolumab to see if it can help people with advanced soft tissue sarcoma who have already received other treatments.
Related topics
Quick answers
How many Metastatic Soft Tissue Sarcoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (5 trials), Belgium (1 trial), France (1 trial), Germany (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 4, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.